JUSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Jushi Holdings Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$0.49−0.03 (-5.50%)
Close on Oct 19, 2026
- Market cap
- $98.11M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2019 to 2025
Gross margin
43.4%−4.1 pts over 5 years
Operating margin
1.8%+22.3 pts over 5 years
Net margin
-26.1%+234.7 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +2.1% | -2.6% | +26.6% | – | |
| Gross profit | -3.7% | +6.1% | +24.3% | – | |
| Operating income | -55.3% | – | – | – | |
| Free cash flow | -90.3% | – | – | – |
Returns and balance sheet
7 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2019 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | 82.8% | |
| Return on assets | – | – | -15.9% | |
| Current ratio | – | – | 1.03 | |
| Debt to equity | – | – | -1.78 | |
| Net debt to EBITDA | – | – | 5.07× | |
| Interest coverage | – | -1.1× | 0.1× | |
| Inventory turnover | – | – | 4.2× | |
| Capex to revenue | – | 28.2% | 6.1% | |
| Diluted shares | – | 108M | 195M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Jushi generated $78.33M from operations and spent $163.72M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$78.33M
Used
$163.72M
Capital expenditure$163.72M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-26.1%
×Asset turnover0.61×
×Equity multiplier-5.21×
=Return on equity, FY202582.8%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -26.1% | 0.61× | -5.21× | 82.8% |
| FY2024 | -18.9% | 0.57× | -16.00× | 172.8% |
| FY2023 | -24.2% | 0.54× | 24.19× | -317.2% |
| FY2022 | -71.2% | 0.48× | 5.14× | -176.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$68.59M
- Cash generatingOperating cash flow above zero$17.73M
- Return on assets improvedROA up on the prior year-10.5% → -15.6%
- Earnings backed by cashOperating cash flow above net income$17.73M vs -$68.59M
- Less leverageLong-term debt to assets fell41.7% → 47.2%
- Better liquidityCurrent ratio rose1.05 → 1.03
- No dilutionShare count did not rise195M → 195M
- Gross margin improvedGross margin up on the prior year45.94% → 43.35%
- More efficientAsset turnover rose0.56 → 0.60